Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

DYAX
FDA Approves Unknown Drug — DYAX CORP.

DYAX Corporation has received FDA clearance for the investigational drug represented by BLA761090, a decision expected to serve as a catalyst for the ...

BIOCODEX,
FDA Approves DIACOMIT — BIOCODEX, INC.

BioCodex's FDA approval of oral Diacomit allows the manufacturer to enter the epilepsy market with its stiripentol-based treatment, potentially drivin...

BIOCODEX,
FDA Approves DIACOMIT — BIOCODEX, INC.

BioCodex, Inc. secured FDA clearance for Diacomit to treat refractory pediatric epileptic encephalopathies, allowing the company to capitalize on the ...

Chain
FDA Approves CHILDRENS IBUPROFEN — Chain Drug Marketing Association Inc.

Chain Drug Marketing Association Inc. has received approval from the U.S. Food and Drug Administration to launch a generic version of Children’s Ibupr...

Pioneer
FDA Approves FEXOFENADINE HYDROCHLORIDE — Pioneer Life Sciences, LLC

# FDA Approves Generic Fexofenadine Hydrochloride for Pioneer Life Sciences Pioneer Life Sciences, LLC received FDA approval for its generic fexofena...

Mayne
FDA Approves ANNOVERA — Mayne Pharma

Mayne Pharma has announced the FDA approval of ANNOVERA (segesterone acetate and ethinyl estradiol) vaginal ring, setting the stage to disrupt the con...

Kyowa
FDA Approves POTELIGEO — Kyowa Kirin, Inc.

# FDA Approves Kyowa Kirin's POTELIGEO for Cutaneous T-Cell Lymphoma Treatment The FDA has approved Kyowa Kirin, Inc.'s POTELIGEO (mogamulizumab-kpkc...

Ironshore
FDA Approves JORNAY PM EXTENDED-RELEASE — Ironshore Pharmaceuticals Inc.

Ironshore Pharmaceuticals Inc. received FDA approval today for JORNAY PM Extended-Release capsules, providing a once-extended release treatment for AD...

Vertex
FDA Approves ORKAMBI — Vertex Pharmaceuticals Incorporated

# FDA Approves Vertex Pharmaceuticals' ORKAMBI for Cystic Fibrosis Treatment Vertex Pharmaceuticals Incorporated announced FDA approval of ORKAMBI (l...

Elite
FDA Approves METHADONE HYDROCHLORIDE — Elite Laboratories, Inc.

Elite Laboratories, Inc. announced the approval of the generic Formulation 2 for Methadone Hydrochloride, marking a new commercial entry into the opio...

Indivior
FDA Approves PERSERIS — Indivior Inc.

FDA approval of Indivior Inc.'s PERSERIS, a risperidone implant, expands the company's market footprint within the long-acting antipsychotic sector, i...

Sagent
FDA Approves GEMCITABINE — Sagent Pharmaceuticals

# FDA Approves Sagent Pharmaceuticals' Generic Gemcitabine Injection Sagent Pharmaceuticals has received FDA approval for its generic gemcitabine hyd...

Zydus
FDA Approves SPIRONOLACTONE — Zydus Lifesciences Limited

Zydus Lifesciences Limited received FDA approval for its generic version of Spirolactone, a potassium-sparing diuretic, likely introducing a new compe...

Accord
FDA Approves DALFAMPRIDINE — Accord Healthcare Inc.

# FDA Approves Generic Dalfampridine from Accord Healthcare Accord Healthcare Inc. received FDA approval for the generic version of dalfampridine, an...

Jazz
FDA Approves EPIDIOLEX — Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals, Inc. secured a significant market foothold following the FDA approval of oral cannabidiol drug Epidiolex, positioning the biotec...

Upsher-Smith
FDA Approves VIGADRONE — Upsher-Smith Laboratories, LLC

Upsher-Smith Laboratories secured FDA approval for its generic Vigabatrin (VIGADRONE) oral formulation on June 21, 2018, via ANDA 210196 to capitalize...

Somerset
FDA Approves VERAPAMIL HYDROCHLORIDE — Somerset Therapeutics, LLC

Somerset Therapeutics, LLC received FDA approval for its intravenous Verapamil Hydrochloride ANDA, introducing another generic alternative to the wide...

Slate
FDA Approves BUPROPION HYDROCHLORIDE XL — Slate Run Pharmaceuticals, LLC

# FDA Approves Slate Run Pharmaceuticals' Generic Bupropion HCl XL Slate Run Pharmaceuticals, LLC has received FDA approval for its generic formulati...

Dr.Reddys
FDA Approves BUPRENORPHINE AND NALOXONE — Dr.Reddys Laboratories Inc

Dr. Reddy’s Laboratories Inc. announced the FDA approval of its buccal Buprenorphine and Naloxone tablets, expanding its portfolio in the opioid depen...

Mylan
FDA Approves BUPRENORPHINE AND NALOXONE — Mylan Pharmaceuticals Inc.

On June 14, 2018, Mylan Pharmaceuticals Inc. received FDA approval to launch Buprenorphine and Naloxone tablets, bringing a potent generic alternative...